Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

BACKGROUND: High ERCC1 expression is thought to be related with resistance to chemotherapy based on platinum. The aim of this study was to present our institutional observations regarding to the association of ERCC1 and overall survival (OS) of the lung adenocarcinoma patients who received chemother...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diagn Pathol
Main Authors: Piljić Burazer, Marina, Mladinov, Suzana, Matana, Antonela, Kuret, Sendi, Bezić, Joško, Glavina Durdov, Merica
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745063/
https://ncbi.nlm.nih.gov/pubmed/31521181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-019-0885-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados